SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-169391
Filing Date
2021-05-21
Accepted
2021-05-21 16:58:33
Documents
6
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 6-K d185923d6k.htm 6-K 11616
2 EX-99.1 d185923dex991.htm EX-99.1 10733
3 EX-99.2 d185923dex992.htm EX-99.2 581452
4 EX-99.3 d185923dex993.htm EX-99.3 16479
5 GRAPHIC g185923g0521215817982.jpg GRAPHIC 2708
6 GRAPHIC g185923g96l71.jpg GRAPHIC 3608
  Complete submission text file 0001193125-21-169391.txt   630411
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 21949893
SIC: 2834 Pharmaceutical Preparations